Table 3.
Clinical Outcomes of RFA vs. no RFA in NVAF patients taking DOACs after propensity score matching
| No RFA(n=1700) | RFA(n=1700) | OR(95%CI) | P value | |
|---|---|---|---|---|
| Total bleeding, n(%) | 185(10.9) | 165(9.7) | 0.880(0.705-1.099) | 0.259 |
| Major Bleeding, n(%) | 34(2.0) | 10(0.6) | 0.290(0.143-0.589) | <0.001 |
| Thrombosis, n(%) | 35(2.1) | 18(1.1) | 0.509(0.287-0.902) | 0.019 |
| All-cause death, n(%) | 52(3.1) | 47(2.8) | 0.901(0.604-1.345) | 0.610 |
| Composite outcomea | 266(15.6) | 224(13.2) | 0.818(0.675-0.991) | 0.040 |
NVAF Non-valvular atrial fibrillation, RFA Radiofrequency ablation, OR Odds ratio, 95%CI 95% Confidence interval
aComposite outcome included all-cause death, thrombosis and total bleeding